Data as of May 24
| -0.13 / -0.41%|
The 15 analysts offering 12-month price forecasts for Thoratec Corp have a median target of 40.00, with a high estimate of 44.00 and a low estimate of 32.00. The median estimate represents a +27.43% increase from the last price of 31.39.
The current consensus among 20 polled investment analysts is to Hold stock in Thoratec Corp. This rating has held steady since May, when it was downgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.